Menu
ncarol.com
  • Home
  • Books
  • Music
  • Manufacturing
  • Book Release
  • Health
  • Asheville Music
  • Real Estate
  • Business
ncarol.com

Relecura Makes Patent Innovation Research Platform Free to Coronavirus Researchers in Wake of Pandemic
ncarol.com/10051865

Trending...
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 109
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 107
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
Relecura Inc
PLEASANTON, Calif. - ncarol.com -- Relecura Inc., a leading provider of AI-powered patent and scientific innovation research,  today announced that Coronavirus researchers across the globe who are working on discovering a solution to the crisis will have free access to its premium research platform until May 31, 2020. Using Relecura's premium research platform, researchers can find and build on existing IP and patent research that will aid them in finding solutions to the current COVID-19 world pandemic.

Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.

"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."

Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.

More on ncarol.com
  • Before Asheville, There Was Cherokee: KayeDinero Reveals Where Her Carolina Chapter Really Began
  • Profit at the Window: Free Webinar Helps Interior Designers Turn Window Treatments Into Revenue
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Local Ecomaids Owner Launches Healthy Home Reset Initiative for Triangle Families

About Relecura:

Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.

Contact
George Koomullil
***@relecura.com


Source: Relecura Inc
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Share your workplace safety solutions at 2027 Applied Ergonomics Conference
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
  • From Detroit Streets to Blue Ridge Mountains: KayeDinero Finds a New Sound in Western North Carolina
  • Why Did KayeDinero Name a Song After Hendersonville?
  • Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
  • Did Asheville's BoomTown Weekend Inspire KayeDinero's Next Move?
  • From City Girl to Mountain Life: KayeDinero Releases "City Girl Saved" From Asheville
  • Lake Norman Philharmonic - Free Community Concert
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
  • Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
  • Ubora Thrive AI Welcomes Ubuntu Holistic Counseling as Strategic Business Ambassador
  • ChargeOn Announces Conversational Payment Management Solution
  • King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 143
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 135
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate - 126
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 116
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 114
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 113
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies - 109
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 109
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 107
  • KeysCaribbean Resorts Offer Savings On Vacations Through Aug. 31, Preview Exceptional Select Fall Rates of Less Than $200/Night - 107

Similar on ncarol.com

  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
  • ChatGPT Leans Mostly on Firms' Own Websites to Decide Which Environmental Consultant to Recommend
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
  • MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
  • Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
  • Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute